investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Generation of Highly Avid Anti-Tumor CTL for Optimal Adoptive Immunotherapy

Naoto Hirano

0 Collaborator(s)

Funding source

National Cancer Institute (NIH)

Related projects

Anne-Claude Gingras

Global approaches to unravel PP2A function

All cancers but non-melanoma skin cancer

Chantal Guillemette

Pharmacogenomics program identifies genomic changes that affect adverse effects and treatment efficacy (CANADA RESEARCH CHAIRHOLDER - Tier 1)

All cancers but non-melanoma skin cancer

Dennis Klinman

Mechanism of action and therapeutic utility of stimulatory CpG oligonucleotides 

All cancers but non-melanoma skin cancer

Carol Thiele

Regulation of Differentiation of Pediatric Embryonal Tumors- Neuroblastoma

All cancers but non-melanoma skin cancer

Pediatric oncology or childhood cancer

Bo Rafn

Oncogene-induced ROS as a driver of tumorigenesis and transformation

All cancers but non-melanoma skin cancer

Sriram Subramaniam

Imaging Cellular Assemblies With Three-Dimensional Electron Microscopy

All cancers but non-melanoma skin cancer

A. K. M. Nur-Ur Rahman

Defining the role of T cell metabolism in HIV-induced chronic immune activation and immune dysfunction.

All cancers but non-melanoma skin cancer

Brian Raught

A Global Ubiquitin-Proteasome System Map

All cancers but non-melanoma skin cancer

Paul Randazzo

Regulation of ADP-Ribosylation Factor

All cancers but non-melanoma skin cancer